Loading...

Rising Regulatory Burdens Will Weaken mRNA Base Despite BST Gains

Published
07 Aug 25
Updated
16 Aug 25
AnalystLowTarget's Fair Value
US$2.00
21.0% overvalued intrinsic discount
16 Aug
US$2.42
Loading
1Y
-73.2%
7D
-3.6%

Author's Valuation

US$2.0

21.0% overvalued intrinsic discount

AnalystLowTarget Fair Value